Currently, GLP-1 patches are not licensed or available for prescribing in the UK
The condition affects approximately 10 million Americans, with another 44 million having low bone density (osteopenia), according to the Bone Health and Osteoporosis Foundation
The primary care physicians at the Primary Care Center of Clear Lake are skilled at addressing a variety of health concerns, including weight loss and management
Among people who planned to quit, 93% had experienced side effects, but only 36% were still losing weight, suggesting that lack of results, not discomfort, drove discontinuation
Cachexia is a multifactorial metabolic syndrome, characterized by weight loss and skeletal muscle loss caused by underlying diseases such as cancer, heart failure and renal failure [5]
Patients who maintain a therapeutic dose (even lower than peak weight-loss doses) preserve appetite suppression and metabolic support